A Cost-Effectiveness Analysis of Pegcetacoplan for the Treatment of Geographic Atrophy-Reference-Cited by-同舟云学术

A Cost-Effectiveness Analysis of Pegcetacoplan for the Treatment of Geographic Atrophy

Published:2024-01 Issue:1 Volume:8 Page:25-31
ISSN:2468-6530
Container-title:Ophthalmology Retina
language:en
Short-container-title:Ophthalmology Retina

Author:

Patel Nimesh A.^ORCID,Al-Khersan Hasenin^ORCID,Yannuzzi Nicolas A.,Lin James^ORCID,Smiddy William E.^ORCID

Publisher

Elsevier BV

Subject

Ophthalmology

Reference11 articles.

1. Avacincaptad pegol for geographic atrophy secondary to age-related macular degeneration: 18-month findings from the GATHER1 trial;Patel;Eye (Lond),2023

2. Complement C3 inhibitor pegcetacoplan for geographic atrophy secondary to age-related macular degeneration: a randomized phase 2 trial;Liao;Ophthalmology,2020

3. Aflibercept monotherapy versus bevacizumab-first for diabetic macular edema: a cost analysis based on Diabetic Retinopathy Clinical Research Network Protocol AC results;Patel;Ophthalmol Retina,2023

4. Intravitreal aflibercept injection for neovascular age-related macular degeneration: ninety-six-week results of the VIEW studies;Schmidt-Erfurth;Ophthalmology,2014

5. HORIZON: an open-label extension trial of ranibizumab for choroidal neovascularization secondary to age-related macular degeneration;Singer;Ophthalmology,2012

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Re: Patel et al.: A cost-effectiveness analysis of pegcetacoplan for the treatment of geographic atrophy. (Ophthalmol Retina. 2024;8:25-31);Ophthalmology Retina;2024-07

2. A Cost Effectiveness Analysis of Avacincaptad Pegol for the Treatment of Geographic Atrophy with Comparison to Pegcetacoplan;Ophthalmology Retina;2024-05

3. Re: Patel et al.: A cost-effectiveness analysis of pegcetacoplan for the treatment of geographic atrophy. (Ophthalmol Retina. 2024;8:25-31);Ophthalmology Retina;2024-02